Dozens of clinical trials for COVID-19 treatments and vaccines are ongoing globally. The much-hyped coronavirus vaccine candidate of AnGes moved closer to starting human trials, say reports.
It would begin clinical trials for its DNA vaccine in July, earlier than previously planned. That report followed the announcement by AnGes that animal trials of the vaccine had confirmed an increase in antibodies in tests it had been conducting with Osaka University since March.
About a dozen experimental vaccines against the coronavirus are in early stages of testing or poised to start, mostly in China, the US and Europe.
It's not clear that any will prove safe and effective. But many work in different ways, and are made with different technologies,